Max Healthcare outlines expansion, medical college plans in Q1FY27 call
NiveshIQ
NSE: MAXHEALTH · Healthcare
Max Healthcare Institute Ltd.
₹884.75▲ ₹24.75 (+2.88%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on MAXHEALTH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Max Healthcare Institute Ltd.
Max Healthcare Institute Limited operates a network of multi‑specialty hospitals and primary care clinics across India, offering a broad spectrum of services from cardiac and oncology to robotic and organ transplant procedures. The company’s revenue drivers include inpatient care, outpatient specialty services, and ancillary services such as Max@Home and Max Lab diagnostics, which together contributed to a 20% revenue rise to ₹9,146 crore in FY27 Q2. Net profit for the quarter fell 15.6% to ₹1,381 crore, largely due to higher operating and tax expenses, yet the company still posted a 10% PAT increase to ₹448 crore. Max Healthcare is expanding its footprint with new hospital openings and upgrades, positioning it ahead of competitors in high‑margin specialty care. The firm’s diversified serv
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹5,406 Cr +18.49% | ₹7,028 Cr +30.01% | ₹8,373 Cr +19.14% |
| EBITDA Margin | 27.60% | 26.30% | 26.79% |
| Net Profit | ₹1,051 Cr -4.74% | ₹1,076 Cr +2.35% | ₹1,442 Cr +34.07% |
| EPS | ₹10.89 | ₹11.07 | ₹14.83 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Max Healthcare MAXHEALTH Q2 FY27 Results Published
Max Healthcare (NSE:MAXHEALTH): How Is Hospital Expansion Shaping FY27 Results?
🔒
+ 3 more stories about Max Healthcare Institute Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹2, 569 Cr, PAT ₹415 Cr, EPS ₹4.26, EBITDA margin 27.7%. Growth context: revenue YoY +20.3%, PAT YoY -15.5%, revenue QoQ +8.6%, PAT QoQ +28.5%.
Management highlights network expansion, capacity ramp‑up, throughput gains, new capacity addition and capex deployment ...
FY26 (last completed FY): revenue ₹8, 373 Cr, PAT ₹1, 442 Cr, EBITDA margin 26.8%, EPS ₹14.83. Year-on-year: revenue YoY...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for MAXHEALTH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track MAXHEALTH alongside your other holdings
Unlock full MAXHEALTH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Max Healthcare Institute Ltd.?
NiveshIQ detects active intelligence signals for Max Healthcare Institute Ltd. (MAXHEALTH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Max Healthcare Institute Ltd.?
Max Healthcare Institute Ltd. operates in the Healthcare sector with a market capitalisation of ₹10,619,062.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.